Global Coronary Artery Disease Medical Devices Market Size By Type (Coronary Stents, PTCA Balloon Catheters), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Coronary Artery Disease (CAD) Medical Devices Market was valued at USD 18.9 billion in 2023 and is projected to surpass USD 32.4 billion by 2031, expanding at a CAGR of 6.9% during the forecast period of 2023–2031. The rising prevalence of coronary artery disease due to aging populations, sedentary lifestyles, and poor dietary habits is fueling demand for advanced medical devices. Increasing adoption of minimally invasive procedures and growing investments in healthcare infrastructure are propelling the growth of coronary artery disease treatment solutions worldwide.

Drivers

Rising Global Burden of Cardiovascular Diseases:

Coronary artery disease is the leading cause of death globally. The increasing incidence is accelerating demand for advanced diagnostics and interventional devices such as stents and angioplasty balloons.

Technological Advancements in Medical Devices:

Next-generation stents with bioresorbable coatings, drug-eluting stents, and robotic-assisted interventions are improving treatment outcomes and expanding patient eligibility for minimally invasive procedures.

Increased Awareness and Early Diagnosis:

Government campaigns and initiatives by non-profits are raising awareness of cardiovascular health, encouraging early screening and diagnosis that lead to higher adoption of CAD medical devices.

Restraints

High Cost of Advanced Devices and Procedures:

The cost of premium CAD devices and interventional procedures can be prohibitive, especially in low- and middle-income countries, limiting accessibility and market penetration.

Stringent Regulatory Approvals:

Medical devices for coronary artery disease are subject to strict regulatory scrutiny, which can delay product launches and increase development costs.

Opportunity

Emerging Markets Expansion:

Countries such as India, Brazil, and China are witnessing improved healthcare infrastructure, greater insurance coverage, and rising disposable incomes, creating lucrative opportunities for market players.

Integration with AI and Remote Monitoring:

Smart devices integrated with AI and telemetry for real-time monitoring of cardiac events are gaining traction, offering untapped growth potential and revolutionizing post-operative care.

Market by System Type Insights

Based on system type, Stents dominated the market in 2023, accounting for over 40% of global revenue. Drug-eluting stents have emerged as a preferred choice due to their ability to reduce restenosis and improve long-term patient outcomes. Meanwhile, catheters are anticipated to witness the fastest growth due to their vital role in diagnostic and interventional cardiology, including angiography and balloon angioplasty.

Market by End-use Insights

The Hospitals segment was the largest end-user in 2023, holding over 60% of the market share. Hospitals are the primary centers for coronary interventions, equipped with advanced cath labs and trained specialists. Ambulatory Surgical Centers (ASCs) are expected to experience robust growth during the forecast period, driven by the demand for cost-effective and same-day cardiac care services.

Market by Regional Insights

North America led the global market in 2023, fueled by high disease prevalence, advanced healthcare systems, and strong reimbursement frameworks. Asia-Pacific is projected to be the fastest-growing region, thanks to rising health awareness, increased healthcare spending, and rapid adoption of modern medical technologies in countries like China and India.

Competitive Scenario

Key players in the global coronary artery disease medical devices market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Biosensors International Group, MicroPort Scientific Corporation, Cardinal Health, and Biotronik SE & Co. KG. These companies are actively pursuing innovations in drug-eluting technologies, AI integration, and strategic partnerships to expand their market footprint.

Scope of Work – Global Coronary Artery Disease Medical Devices Market

Report Metric Details

Market Size (2023) USD 18.9 Billion

Projected Market Size (2031) USD 32.4 Billion

CAGR (2023–2031) 6.9%

Market Segments By System Type (Stents, Catheters, Guidewires, etc.), End-use (Hospitals, ASCs, Clinics), Region

Growth Drivers Rising prevalence of CAD, Technological advancements, Early diagnosis & screening

Opportunities Expansion in emerging markets, Smart/AI-enabled monitoring devices

Key Market Developments

2023: Medtronic launched the next-generation Resolute Onyx DES, focusing on faster healing and reduced thrombosis rates.

2024: Abbott received FDA approval for a wireless pressure guidewire designed to improve coronary diagnostics.

2025: Boston Scientific announced a partnership with a health-tech firm to integrate AI into its stent placement planning software for cardiologists.

FAQs

1) What is the current market size of the Global Coronary Artery Disease Medical Devices Market?

The market was valued at USD 18.9 billion in 2023.

2) What is the major growth driver of the Global Coronary Artery Disease M